Probiotics, A New Frontier in Oral Health: Unraveling the Efficacy of Probiotic Metabolites vs. Chlorhexidine on Streptococcus mutans in Dental Plaque

Author:

Mehwash Kashif ,Mahmooda Kazmi

Abstract

The battle against dental caries has long been fought with conventional antimicrobial agents, with Chlorhexidine leading the charge. However, recent research has delved into the potential of probiotic metabolites as an alternative or adjunctive therapy in the quest for better oral health. In this editorial, we explore the emerging evidence surrounding the efficacy of probiotic metabolites compared to Chlorhexidine, specifically targetting local clinical isolates of Streptococcus mutans within dental plaque. Streptococcus mutans, a key player in the formation of dental plaque, has been a prime target for antimicrobial interventions due to its significant role in tooth decay. Chlorhexidine, a widely used antiseptic, has been a stalwart in dental care. However, its efficacy and potential side effects have prompted researchers to seek alternative approaches. Probiotic metabolites, byproducts of beneficial bacteria, have emerged as a promising avenue, with studies suggesting their ability to promote oral health by modulating the microbial balance.1 Recent studies have begun to unravel the intricate interactions between probiotic metabolites and Streptococcus mutans. These investigations have not only explored the direct antimicrobial effects but also the potential for probiotics to influence the overall microbial environment in the oral cavity. The comparison with Chlorhexidine, a gold standard in dental care, adds depth to our understanding of these alternative therapies.2 The evidence supporting the efficacy of probiotic metabolites in controlling Streptococcus mutans is not only encouraging but also challenges the status quo. A study by Gong SG et al. (2023) demonstrated that probiotic metabolites significantly reduced the growth of Streptococcus mutans in vitro, highlighting their potential as a potent antimicrobial agent.3 This finding is particularly promising given the increasing concerns about antibiotic resistance and the need for sustainable alternatives. Continued...

Publisher

Pakistan Medical Association

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3